SEEL
Seelos Therapeutics Inc
Halal Rating :
Last Price
$1.28
Last updated:
Market Cap
-
7D Change
245.95%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for central nervous system disorders and other rare diseases. The company's pipeline includes treatments for acute suicidal ideation and behavior in major depressive disorder, amyotrophic lateral sclerosis (ALS), Sanfilippo syndrome, and Parkinson's disease.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| June 30, 2024 | $376000.0 | $3.54m | - | $23000.0 | 0.00% | 0.65% |
| March 31, 2024 | $579000.0 | $8.15m | - | $1.52m | 0.00% | 18.60% |
| Dec. 31, 2023 | $653000.0 | $8.68m | - | $19000.0 | 0.00% | 0.22% |
Company Impact
Help us evaluate Seelos Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.